Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $100.8300 (1.03%) ($98.9500 - $102.4900) on Tue. Nov. 17, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 67 | Latest Price | $100.8300(1.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) XBI(57%) IWO(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.725% in a week (0% probabilities). VIXM(-18%) TLT(-16%) UUP(-6%) GDXJ(-5%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
5 Day Moving Average | $98.24(2.64%) | 10 Day Moving Average | $97.27(3.66%) | 20 Day Moving Average | $94.34(6.88%) | To recent high | -1.1% | To recent low | 22.8% | Market Cap | $1.62b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |